Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Competing risks analysis of correlated failure time data.

Bingshu E Chen1, Joan L Kramer, Mark H Greene

  • 1Biostatistics Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD 20852, USA. bingshu@chenstat.com

Biometrics
|August 8, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of cancer antigen 15-3 with distant recurrence in immunohistochemically defined breast cancer subtypes in Canadian Cancer Trials Group MA.32.

JNCI cancer spectrum·2026
Same author

A phase 1 study of R-GDP-venetoclax before autologous transplant in relapsed/refractory large B-cell lymphoma (CCTG LY.18).

Blood neoplasia·2026
Same author

Exploration of BMI and circulating metabolic factors as predictors of metformin benefit in CCTG MA.32.

JNCI cancer spectrum·2026
Same author

People Living with HIV Eligibility in Canadian Cancer Clinical Trials.

Current oncology (Toronto, Ont.)·2026
Same author

Primary refractory disease in large B-cell lymphoma: definition and outcomes from a secondary analysis of the LY.12 clinical trial.

Blood advances·2026
Same author

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

NPJ genomic medicine·2025
Same journal

Interim analysis in sequential multiple assignment randomized trials for survival outcomes.

Biometrics·2026
Same journal

Acknowledgment of Referees 2025.

Biometrics·2026
Same journal

Fast penalized generalized estimating equations for large longitudinal functional datasets.

Biometrics·2026
Same journal

Causally-interpretable random-effects meta-analysis.

Biometrics·2026
Same journal

Statistical inference for mean function of partially observed functional time series.

Biometrics·2026
Same journal

Subgroup identification via Interaction Tree and Mixed Model for Repeated Measures with application to Alzheimer's disease.

Biometrics·2026
See all related articles

This study introduces new statistical methods for analyzing competing risks data with correlated event times within clusters, crucial for genetic studies. The methods provide accurate estimates and robust tests, improving analysis of complex health outcomes.

Area of Science:

  • Biostatistics
  • Epidemiology
  • Clinical Genetics

Background:

  • Correlated event times within clusters are common in clinical genetic studies.
  • Standard competing risks methods often fail to account for this correlation.
  • Accurate analysis is essential for understanding disease incidence and risk factors.

Purpose of the Study:

  • To develop statistical methods for competing risks analysis with correlated event times.
  • To provide robust estimators and hypothesis tests for clustered data.
  • To apply these methods to a hereditary breast and ovarian cancer cohort study.

Main Methods:

  • Developed a nonparametric estimator for cumulative incidence in clustered competing risks data.
  • Derived robust standard errors accounting for within-cluster correlation.

Related Experiment Videos

  • Modified existing two-sample tests and proposed a new landmark test for correlated data.

    • Main Results:

    • The proposed estimators are asymptotically unbiased.
    • Modified test statistics effectively control Type I error in simulations.
    • Test power varies with correlation, indicating context-dependent optimal test selection.

    Conclusions:

    • The developed methods offer a robust approach to competing risks analysis in clustered settings.
    • These methods are applicable to family-based studies, such as hereditary breast and ovarian cancer.
    • Accounting for within-family correlation is vital for accurate cumulative incidence estimation.